San Diego, CA, United States of America

Traci Roberts


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Traci Roberts in Immunology

Introduction

Traci Roberts is a distinguished inventor based in San Diego, California, known for her significant contributions to the field of immunology. With a focus on innovative treatments, she holds a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Traci Roberts holds a patent for her invention titled "Antibodies directed against IL-17." This invention relates to an isolated interleukin-17 (IL-17)-binding agent that comprises an immunoglobulin heavy chain polypeptide and an immunoglobulin light chain polypeptide. Specifically, the heavy chain includes sequences such as SEQ ID NO: 1, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 78, or SEQ ID NO: 79. The light chain involves SEQ ID NO: 23, with the possibility of modifying specific residues of these sequences. This innovative agent is designed to treat IL-17-mediated diseases, heralding a new avenue for therapeutic interventions.

Career Highlights

As a member of Anaptysbio, Inc., Traci has played a pivotal role in driving forward the company's mission to develop novel immunotherapies. Her work in the laboratory not only emphasizes her ability to navigate complex scientific challenges but also places her at the forefront of medical innovation. Understanding the implications of her patent, Traci's research contributes significantly to the ongoing battle against diseases characterized by IL-17 activity.

Collaborations

Throughout her career, Traci Roberts has collaborated with esteemed colleagues, including Robert A. Horlick and David J. King. Their combined expertise has enhanced the depth and breadth of research undertaken at Anaptysbio, Inc., fostering an environment that encourages shared knowledge and cutting-edge discoveries in immunology.

Conclusion

Traci Roberts exemplifies the spirit of innovation in the scientific community. With her patent on IL-17-binding agents, she is poised to make a lasting impact in the treatment of IL-17-mediated diseases. Her collaborative efforts with fellow researchers further underline the importance of teamwork in scientific advancement. As the field of immunology continues to evolve, Traci's contributions are sure to influence future breakthroughs in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…